Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Oncotargets and Therapy|July 29, 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trialAlexandra von Au, Eva Milloth, Ingo Diel, et al.
Archives of Gynecology and Obstetrics|February 9, 2017
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center studyAlexandra von Au, Mona Klotzbuecher, Lorenz Uhlmann, et al.
Tumori|November 2, 2021
Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factorsEva Meixner, Nathalie Arians, Nina Bougatf, et al.
Cancer Research|August 4, 2006
Heparanase: a new metastasis-associated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytesNora Sommerfeldt, Philipp Beckhove, Yingzi Ge, et al.
Cancers|April 30, 2020
Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast CancerThomas M Deutsch, Stefan Stefanovic, Manuel Feisst, et al.
Anti-Cancer Drugs|November 20, 2013
Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancerJoachim Rom, Sarah Bechstein, Christoph Domschke, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2017
Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1Anchana Rathinasamy, Christoph Domschke, Yingzi Ge, et al.
Archives of Gynecology and Obstetrics|August 18, 2022
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancerAlexandra von Au, Samra Shencoru, Lorenz Uhlmann, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2013
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trialChristoph Domschke, Yingzi Ge, Isa Bernhardt, et al.
Archives of Gynecology and Obstetrics|March 3, 2022
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancerChiara Fischer, Thomas M Deutsch, Manuel Feisst, et al.
Pageof 7